Health in Sao Tome and Principe

1,211 indicators covering health for Sao Tome and Principe.

IndicatorLatest Year10-yr change Rank
Domestic private health expenditure (PVT-D) per capita in US$ 32.69 2023 up 57.3% 155th
Domestic general government health expenditure (GGHE-D) per capita in 63.23 2023 up 51.4% 138th
Total healthcare spending as a share of GDP 5.8% 2023 down 35.4% 110th
Health spending as a share of total government spending 8.8% 2023 up 4.0% 117th
Mumps - number of reported cases 28 2025 76th
Incidence of tuberculosis (per 100 000 population) 16 2023 down 40.7% 30th
Estimated antiretroviral therapy coverage among people living with HIV 97.0% 2025 up 86.5% 2nd
Share of one-year-olds vaccinated against Haemophilus influenzae type B 87.0% 2024 down 8.4% 117th
External health expenditure (EXT) per capita in US$ 75.13 2023 up 21.1% 11th
Congenital Rubella Syndrome - number of reported cases 0 2021 16th
Cholera reported cases 119 reported cases 2008 41st
People with basic handwashing facilities including soap and water 43.1% 2024 down 9.7% 63rd
Nursing and midwifery personnel 490 2022 up 10.9% 174th
Nursing personnel 440 2022 down 0.5% 176th
Cholera reported deaths 4 reported deaths 2008 30th
People using safely managed drinking water services, rural 24.6% 2024 up 11.2% 55th
Raised blood pressure (SBP>=140 OR DBP>=90) 40.86 2019 down 8.4% 9th
Raised blood pressure (SBP>=140 OR DBP>=90) 37.39 2019 down 7.3% 37th
Hypertension: diagnosis coverage among adults aged 30-79 with 49.8% 2019 up 42.7% 126th
Hypertension among adults aged 30-79 years, prevalence 45.1 2019 down 4.0% 24th
Hypertension effective treatment coverage (controlled hypertension) 9.4% 2019 up 84.3% 162nd
Hypertension: effective treatment coverage (controlled hypertension) 9.2% 2019 up 76.9% 157th
Hypertension treatment coverage among adults aged 30-79 with 26.7% 2019 up 42.8% 143rd
Hypertension treatment coverage among adults aged 30-79 with 28.6% 2019 up 42.3% 141st
Hypertension: diagnosis coverage among adults aged 30-79 with 48.1% 2019 up 44.9% 122nd
Hypertension among adults aged 30-79 years, prevalence, crude 41.2 2019 down 3.3% 54th
Pneumococcal conjugate second or third-dose vaccines (PCVc) 86.0% 2025 down 10.4% 92nd
People with basic handwashing facilities including soap and water 62.8% 2024 up 60.3% 67th
Number of one-year-olds who are not vaccinated against rubella 812.63 one-year-olds 2023 up 86.7% 133rd
Estimated number of malaria cases 7,087 Cases 2024 up 304.0% 61st
Treatment success rate: previously treated TB cases 100 2023 up 138.1% 1st
Proportion of births attended by skilled health personnel 96.8% 2019 up 18.5% 99th
Adolescent birth rate 0.3744 2018 down 91.9% 84th
Reported number of people receiving antiretroviral therapy 1,007 2025 up 91.1% 130th
Estimated number of people (all ages) living with HIV 1,000 2025 unchanged 131st
Prevalence of HIV among adults aged 15 to 49 0.6% 2025 down 33.3% 55th
Prevalence of insufficient physical activity among adults aged 18+ 16.6% 2022 up 3.9% 142nd
Prevalence of insufficient physical activity among adults aged 18+ 18.2% 2022 up 2.0% 139th
3.b.1 Proportion of surviving infants receiving 3 doses of 97 2022 up 1.0% 39th
Nursing and midwifery personnel 21.65 2022 down 1.9% 126th
Reported cases of paralytic polio from wild vs. vaccine-derived polioviruses 0 cases 2023 24th
Vaccination against measles vs. share who think vaccines are unsafe 87.0% 2024 up 22.5% 82nd
Share of children fully vaccinated against measles 87.0% 2024 up 22.5% 82nd
Reported cases of paralytic polio from vaccine-derived viruses 0 cases 2023 24th
TB patients with known HIV status 97.0% 2024 down 3.0% 61st
Number of people dying from HIV-related causes 100 2025 unchanged 99th
Number of new HIV infections 100 2025 unchanged 121st
Confirmed cases of RR-/MDR-TB 1 2024 down 50.0% 155th
Number of one-year-olds who are not vaccinated against Haemophilus influenzae type B 812.63 one-year-olds 2023 up 344.9% 152nd
Capital health expenditure 0.2% 2021 down 6.3% 72nd
Adolescent birth rate 0.3744 2018 down 91.9% 83rd
Tested TB patients HIV-positive 19.0% 2024 up 5.6% 29th
Cause of death, by other COVID-19 pandemic-related outcomes, ages 0.0% 2021 3rd
Cause of death, by other COVID-19 pandemic-related outcomes, ages 0-4 0.0% 2021 3rd
Cause of death, by other COVID-19 pandemic-related outcomes, ages 0.5% 2021 31st
Cause of death, by other COVID-19 pandemic-related outcomes, ages 1.1% 2021 38th
Cause of death, by other COVID-19 pandemic-related outcomes, ages 5-14 0.9% 2021 41st
Cause of death, by other COVID-19 pandemic-related outcomes, ages 2.0% 2021 73rd
Cause of death, by other COVID-19 pandemic-related outcomes, ages 3.2% 2021 64th
Cause of death, by other COVID-19 pandemic-related outcomes, ages 2.7% 2021 66th